bioRxivSystems BiologyPreprint
Characterisation of type 2 diabetes progression with regulatory network
Maria Barrera, Marcia HiriartiD, G. Cocho, Carlos Villarreal
Abstract
Type 2 diabetes develops due to beta cell exhaustion with accompanying decrease in insulin secretion, leading to hyperglycemia and eventual damage of nerve, kidney, and eye tissues. It is usually preceded by metabolic alterations related to insulin signaling, inflammatory pathways, or intracellular glucose processing, encompassed as metabolic syndrome. We propose a regulatory network for components of pancreatic-beta cells playing an essential role in the disease. The network interactions are expressed as continuous fuzzy logic propositions. The dynamical modeling of the network allows to portray the disease progression as a transit between steady states associated to health, metabolic syndrome, and diabetes, each state defined by specific expression patterns of the network components. Transitions between equilibrium states are due to altered expression or functional exhaustion associated to modifications of characteristic decay rates of cellular components. This approach let us identify functional modules that may eventually drive the transit from health to diabetes. The analysis reveals that underexpression of protein kinase B and X-box binding protein 1, with concomitant overexpression of lipopolysaccharides and thioredoxin interacting protein are key factors in the transition from health to disease.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling disease progression in newly diagnosed type 2 diabetes
- AFF3 and BACH2 are master regulators of metabolic inflexibility, β/α-cell transition, and dedifferentiation in type 2 diabetes
J. Son, H. Ding, … A. Califano·bioRxiv·Sep 12, 2019
- Causal network perturbation analysis identifies known and novel type-2 diabetes driver genes
Yue Zhao, Hash Brown Taha, … Sheng Li·bioRxiv·May 22, 2024
- Compromised beta-cell identity in type 2 diabetes
Pritha Dutta, Nadège Merabet, … Peter M. A. Sloot·bioRxiv·Mar 20, 2023
- Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories toward type 2 diabetes
Leonore Wigger, Marko Barovic, … Michele Solimena·Nature MetabolismPeer-reviewed·Jun 28, 2021
- In vivo phosphoproteomics reveals pathogenic signaling changes in diabetic islets
Francesca Sacco, Anett Seelig, … Matthias Mann·Cell MetabolismPeer-reviewed·Mar 14, 2019